Compugen (CGEN) Interest & Investment Income (2014 - 2015)

Compugen (CGEN) posted quarterly Interest & Investment Income of $172000.0 for Q3 2015, up 121.45% year-over-year from $77671.2 in Q3 2014, and up 121.45% on a QoQ basis from -$802000.0 in Q3 2014.

Compugen (CGEN) Interest & Investment Income (2014 - 2015) Analysis & Trends

Compugen has reported Interest & Investment Income for 2 years, with the latest figure at $172000.0 in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 48.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 35.58 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 27.90 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 5.13 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 28.14 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 10.98 Mn
10 Compugen 227.88 Mn 136.13 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2015 172,000.00
Sep 30, 2014 -802,000.00